Emerging Biomarkers in Heart Failure
Key result
Novel applications of established biomarkers and emerging assays for heart failure syndromes have led to growing interest in their widespread use for patient evaluation and management.
Population
Patients with heart failure syndromes
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
May support expanded HF biomarker use in evaluation; leaves open outcome impact pending prospective validation.
Structured PICO
P
Population
Patients with heart failure syndromes
I
Intervention
Biomarker testing (including established biomarkers like natriuretic peptides and novel biomarkers of myocyte stretch, necrosis, inflammation, oxidative stress, extracellular matrix turnover, neurohormones, and extracardiac processes)
This review highlights the growing role of both established and emerging biomarkers in the evaluation, risk stratification, and management of heart failure.
Cite This Study
Kimmenade et al. (2011) conducted a review in Heart failure. Biomarker testing was evaluated. Novel applications of established biomarkers and emerging assays for heart failure syndromes have led to growing interest in their widespread use for patient evaluation and management.